Literature DB >> 3141278

Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG.

C Abou-Zeid1, T L Ratliff, H G Wiker, M Harboe, J Bennedsen, G A Rook.   

Abstract

Fibronectin (FN)-binding antigens are prominent components of short-term culture supernatants of Mycobacterium tuberculosis. In 3-day-old supernatants, a 30-kilodalton (kDa) protein was identified as the major FN-binding molecule. In 21-day-old supernatants, FN bound to a double protein band of 30 and 31 kDa, as well as to a group of antigens of larger molecular mass (57 to 60 kDa). FN-binding molecules in this size range, but not of 30 to 31 kDa, were also found in sonicates. We showed that the 31- and 30-kDa FN-binding bands correspond to components A and B of the BCG85 complex, previously shown to be abundant in culture supernatants of Mycobacterium bovis BCG. Thus, a polyclonal antibody to the BCG85 complex bound to the 30- and 31-kDa antigens and inhibited binding of FN to them on immunoblots of the culture filtrates. Similarly, FN bound to the purified components of the BCG85 complex, and this binding was blocked by the antibody. A monoclonal antibody, HYT27, also bound both to the BCG85 components A and B and to the 30- and 31-kDa FN-binding molecules of M. tuberculosis, but it did not block the binding of FN. Related molecules appear to be present on the surface of BCG and to mediate the binding of BCG to FN-coated plastic surfaces, since this binding could also be blocked by the polyclonal anti-BCG85 antibody and by the purified components of BCG85, particularly component A, but not by monoclonal antibody HYT27. The binding of these mycobacterial antigens to FN appears to be of very high affinity, and we suggest that this property of major secreted antigens of M. tuberculosis indicates an important role in mycobacterial disease and in the binding of BCG to tumor cells during immunotherapy of bladder cancer.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141278      PMCID: PMC259698          DOI: 10.1128/iai.56.12.3046-3051.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose.

Authors:  J Kyhse-Andersen
Journal:  J Biochem Biophys Methods       Date:  1984-12

3.  Characterization of the binding domains in the fragments cleaved by cathepsin G from human plasma fibronectin.

Authors:  T Vartio
Journal:  Eur J Biochem       Date:  1982-04-01

4.  Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions.

Authors:  M Vuento; A Vaheri
Journal:  Biochem J       Date:  1979-11-01       Impact factor: 3.857

5.  Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG.

Authors:  J De Bruyn; K Huygen; R Bosmans; M Fauville; R Lippens; J P Van Vooren; P Falmagne; M Weckx; H G Wiker; M Harboe
Journal:  Microb Pathog       Date:  1987-05       Impact factor: 3.738

6.  Fibronectin binding to a Streptococcus pyogenes strain.

Authors:  P Speziale; M Höök; L M Switalski; T Wadström
Journal:  J Bacteriol       Date:  1984-02       Impact factor: 3.490

7.  I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages.

Authors:  G A Rook; B R Champion; J Steele; A M Varey; J L Stanford
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

8.  Interaction of the 70,000-mol-wt amino-terminal fragment of fibronectin with the matrix-assembly receptor of fibroblasts.

Authors:  P J McKeown-Longo; D F Mosher
Journal:  J Cell Biol       Date:  1985-02       Impact factor: 10.539

Review 9.  Fibronectins: multifunctional modular glycoproteins.

Authors:  R O Hynes; K M Yamada
Journal:  J Cell Biol       Date:  1982-11       Impact factor: 10.539

10.  Fibronectin mediates Treponema pallidum cytadherence through recognition of fibronectin cell-binding domain.

Authors:  D D Thomas; J B Baseman; J F Alderete
Journal:  J Exp Med       Date:  1985-03-01       Impact factor: 14.307

View more
  82 in total

1.  Antibody repertoire against culture filtrate antigens in wild house mice infected with Mycobacterium bovis BCG.

Authors:  K Huygen; K Palfliet; F Jurion; C Lenoir; J P van Vooren
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages.

Authors:  L Y Armitige; C Jagannath; A R Wanger; S J Norris
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Humoral responses against the 85A and 85B antigens of Mycobacterium bovis BCG in patients with leprosy and tuberculosis.

Authors:  J P Van Vooren; A Drowart; J De Bruyn; P Launois; J Millan; E Delaporte; M Develoux; J C Yernault; K Huygen
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

4.  Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.

Authors:  A Macfarlane; R Mondragon-Gonzalez; F Vega-Lopez; B Wieles; J de Pena; O Rodriguez; R Suarez y de la Torre; R R de Vries; T H Ottenhoff; H M Dockrell
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

5.  T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis.

Authors:  P Andersen; D Askgaard; L Ljungqvist; M W Bentzon; I Heron
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

6.  Cloning and expression of the gene for the cross-reactive alpha antigen of Mycobacterium kansasii.

Authors:  K Matsuo; R Yamaguchi; A Yamazaki; H Tasaka; K Terasaka; T Yamada
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

7.  Evidence for three separate genes encoding the proteins of the mycobacterial antigen 85 complex.

Authors:  H G Wiker; K Sletten; S Nagai; M Harboe
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

8.  Cloning and sequencing of the gene for alpha antigen from Mycobacterium avium and mapping of B-cell epitopes.

Authors:  N Ohara; K Matsuo; R Yamaguchi; A Yamazaki; H Tasaka; T Yamada
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

9.  The mycobacterial secreted antigen 85 complex possesses epitopes that are differentially expressed in human leprosy lesions and Mycobacterium leprae-infected armadillo tissues.

Authors:  A Rambukkana; J D Burggraaf; W R Faber; M Harboe; P Teeling; S Krieg; P K Das
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

10.  Bacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents.

Authors:  Natalie A Parlane; D Neil Wedlock; Bryce M Buddle; Bernd H A Rehm
Journal:  Appl Environ Microbiol       Date:  2009-10-16       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.